Dummer R, Vermeer MH, Scarisbrick JJ, Kim YH, Stonesifer C, Tensen CP, et al. Cutaneous T cell lymphoma. Nat Rev Dis Primers. 2021;7(1):61.
Jawed SI, Myskowski PL, Horwitz S, Moskowitz A, Querfeld C. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I Diagnosis: clinical and histopathologic features and new molecular and biologic markers. J Am Acad Dermatol. 2014;70(2):205.e1-16.
Vij A, Duvic M. Prevalence and severity of pruritus in cutaneous T cell lymphoma. Int J Dermatol. 2012;51(8):930–4.
Wright A, Wijeratne A, Hung T, Gao W, Whittaker S, Morris S, et al. Prevalence and severity of pruritus and quality of life in patients with cutaneous T-cell lymphoma. J Pain Symptom Manag. 2013;45(1):114–9.
Misery L. Pruritus in cutaneous T-cell lymphomas. In: Carstens E, Akiyama T, editors. Itch: mechanisms and treatment. Boca Raton (FL): CRC Press; 2014.
Ottevanger R, van Beugen S, Evers A, Willemze R, Vermeer M, Quint K. Quality of life in patients with mycosis fungoides and Sézary syndrome: a systematic review of the literature. J Eur Acad Dermatol Venereol. 2021;35(12):2377–87.
Article CAS PubMed PubMed Central Google Scholar
Gonzalez BR, Zain J, Rosen ST, Querfeld C. Tumor microenvironment in mycosis fungoides and Sézary syndrome. Curr Opin Oncol. 2016;28(1):88–96.
Serrano L, Martinez-Escala ME, Zhou XA, Guitart J. Pruritus in cutaneous T-cell lymphoma and its management. Dermatol Clin. 2018;36(3):245–58.
Article CAS PubMed Google Scholar
Hashimoto T, Nattkemper LA, Kim HS, Kursewicz CD, Fowler E, Shah SM, et al. Itch intensity in prurigo nodularis is closely related to dermal interleukin-31, oncostatin M, IL-31 receptor alpha and oncostatin M receptor beta. Exp Dermatol. 2021;30(6):804–10.
Article CAS PubMed Google Scholar
Sonkoly E, Muller A, Lauerma AI, Pivarcsi A, Soto H, Kemeny L, et al. IL-31: a new link between T cells and pruritus in atopic skin inflammation. J Allergy Clin Immunol. 2006;117(2):411–7.
Article CAS PubMed Google Scholar
Singer EM, Shin DB, Nattkemper LA, Benoit BM, Klein RS, Didigu CA, et al. IL-31 is produced by the malignant T-cell population in cutaneous T-Cell lymphoma and correlates with CTCL pruritus. J Invest Dermatol. 2013;133(12):2783–5.
Article CAS PubMed Google Scholar
Möbs M, Gryzik S, Haidar A, Humme D, Beyer M, Vandersee S. Analysis of the IL-31 pathway in mycosis fungoides and Sézary syndrome. Arch Dermatol Res. 2015;307:479–85.
Cedeno-Laurent F, Singer EM, Wysocka M, Benoit BM, Vittorio CC, Kim EJ, et al. Improved pruritus correlates with lower levels of IL-31 in CTCL patients under different therapeutic modalities. Clin Immunol. 2015;158(1):1–7.
Article CAS PubMed PubMed Central Google Scholar
Nattkemper LA, Martinez-Escala M-E, Gelman AB, Singer EM, Rook AH, Guitart J, et al. Cutaneous T-cell lymphoma and pruritus: the expression of IL-31 and its receptors in the skin. Acta Derm Venereol. 2016;96(7):894–8.
Article CAS PubMed Google Scholar
Olszewska B, Żawrocki A, Gleń J, Lakomy J, Karczewska J, Zabłotna M, et al. Interleukin-31 is overexpressed in skin and serum in cutaneous T-cell lymphomas but does not correlate to pruritus. Postepy Dermatol Alergol. 2020;39(1):81–7.
Article PubMed PubMed Central Google Scholar
Papadavid E, Economidou J, Psarra A, Kapsimali V, Mantzana V, Antoniou C, et al. The relevance of peripheral blood T-helper 1 and 2 cytokine pattern in the evaluation of patients with mycosis fungoides and Sézary syndrome. Br J Dermatol. 2003;148(4):709–18.
Article CAS PubMed Google Scholar
Guenova E, Watanabe R, Teague JE, Desimone JA, Jiang Y, Dowlatshahi M, et al. TH2 cytokines from malignant cells suppress TH1 responses and enforce a global TH2 bias in leukemic cutaneous T-cell lymphoma TH2 cytokines from malignant cells suppress TH1 in L-CTCL. Clin Cancer Res. 2013;19(14):3755–63.
Article CAS PubMed PubMed Central Google Scholar
Geskin LJ, Viragova S, Stolz DB, Fuschiotti P. Interleukin-13 is overexpressed in cutaneous T-cell lymphoma cells and regulates their proliferation. Blood. 2015;125(18):2798–805.
Article CAS PubMed PubMed Central Google Scholar
Dummer R, Heald PW, Nestle FO, Ludwig E, Laine E, Hemmi S, et al. Sezary syndrome T-cell clones display T-helper 2 cytokines and express the accessory factor-1 (interferon-gamma receptor beta-chain). Blood. 1996;88(4):1383–9.
Article CAS PubMed Google Scholar
Suga H, Sugaya M, Miyagaki T, Ohmatsu H, Fujita H, Kagami S, et al. Association of nerve growth factor, chemokine (CC motif) ligands and immunoglobulin E with pruritus in cutaneous T-cell lymphoma. Acta Derm Venereol. 2013;93(2):144–9.
Article CAS PubMed Google Scholar
Hashimoto T, Mishra SK, Olivry T, Yosipovitch G. Periostin, an emerging player in itch sensation. J Invest Dermatol. 2021;141(10):2338–43.
Article CAS PubMed Google Scholar
Takahashi N, Sugaya M, Suga H, Oka T, Kawaguchi M, Miyagaki T, et al. Thymic stromal chemokine TSLP acts through Th2 cytokine production to induce cutaneous T-cell lymphoma TSLP in cutaneous T-celllLymphoma. Cancer Res. 2016;76(21):6241–52.
Article CAS PubMed Google Scholar
Murota H, Lingli Y, Katayama I. Periostin in the pathogenesis of skin diseases. Cell Mol Life Sci. 2017;74:4321–8.
Article CAS PubMed Google Scholar
Nakashima C, Ishida Y, Kitoh A, Otsuka A, Kabashima K. Interaction of peripheral nerves and mast cells, eosinophils, and basophils in the development of pruritus. Exp Dermatol. 2019;28(12):1405–11.
Article CAS PubMed Google Scholar
Rüdrich U, Gehring M, Papakonstantinou E, Illerhaus A, Engmann J, Kapp A, et al. Eosinophils are a major source of interleukin-31 in bullous pemphigoid. Acta Derm Venereol. 2018;98(8):766–71.
Wong L-S, Yen Y-T, Lee C-H. The implications of pruritogens in the pathogenesis of atopic dermatitis. Int J Mol Sci. 2021;22(13):7227.
Article CAS PubMed PubMed Central Google Scholar
Hashimoto T, Kursewicz CD, Fayne RA, Nanda S, Shah SM, Nattkemper L, et al. Pathophysiologic mechanisms of itch in bullous pemphigoid. J Am Acad Dermatol. 2020;83(1):53–62.
Article CAS PubMed Google Scholar
Shimizu K, Andoh T, Makino T, Yoshihisa Y, Mizawa M, Shimizu T. Mechanisms of itching in mycosis fungoides: grade of itching correlates with eosinophil infiltration and kallikrein 5 expression. Eur J Dermatol. 2019;29:268–73.
Article CAS PubMed Google Scholar
Kural YB, Su O, Onsun N, Uras AR. Atopy, IgE and eosinophilic cationic protein concentration, specific IgE positivity, eosinophil count in cutaneous T cell lymphoma. Int J Dermatol. 2010;49(4):390–5.
Article CAS PubMed Google Scholar
Fredholm S, Gjerdrum LMR, Willerslev-Olsen A, Petersen DL, Nielsen IØ, Kauczok C-S, et al. STAT3 activation and infiltration of eosinophil granulocytes in mycosis fungoides. Anticancer Res. 2014;34(10):5277–86.
Günther C, Wozel G, Meurer M, Pfeiffer C. Up-regulation of CCL11 and CCL26 is associated with activated eosinophils in bullous pemphigoid. Clin Exp Immunol. 2011;166(2):145–53.
Article PubMed PubMed Central Google Scholar
Rabenhorst A, Schlaak M, Heukamp LC, Förster A, Theurich S, von Bergwelt-Baildon M, et al. Mast cells play a protumorigenic role in primary cutaneous lymphoma. Blood. 2012;120(10):2042–54.
Article CAS PubMed Google Scholar
Eder J, Rogojanu R, Jerney W, Erhart F, Dohnal A, Kitzwögerer M, et al. Mast cells are abundant in primary cutaneous T-cell lymphomas: results from a computer-aided quantitative immunohistological study. PLoS ONE. 2016;11(11): e0163661.
Article PubMed PubMed Central Google Scholar
Ahern K, Gilmore ES, Poligone B. Pruritus in cutaneous T-cell lymphoma: a review. J Am Acad Dermatol. 2012;67(4):760–8.
Article PubMed PubMed Central Google Scholar
Terhorst-Molawi D, Lohse K, Ginter K, Puhl V, Metz M, Hu M, et al. Mast cells and tryptase are linked to itch and disease severity in mycosis fungoides: results of a pilot study. Front Immunol. 2022;13: 930979.
Article CAS PubMed PubMed Central Google Scholar
Ui H, Andoh T, Lee J-B, Nojima H, Kuraishi Y. Potent pruritogenic action of tryptase mediated by PAR-2 receptor and its involvement in anti-pruritic effect of nafamostat mesilate in mice. Eur J Pharmacol. 2006;530(1–2):172–8.
Comments (0)